May Health

May Health, formerly known as AblaCare, is a medical device company at the clinical stage that is committed to developing more treatment options for patients with polycystic ovary syndrome. The company is currently studying its Ovarian Rebalancing™ technology in clinical trials; Ovarian Rebalancing is a new approach to addressing fertility issues associated with polycystic ovary syndrome and has the potential to become a safe, relatively simple option for inducing natural ovulation. May Health is led by a team of serial medtech and women's health entrepreneurs and executives with extensive experience in product development, validation, and launch.